Prevention Programs

Age, lifestyle, inheritance and other factors influence our health, therefore, take the opportunity to test yourself and your relatives.

Prevention programs are implemented to diagnose a disease in early stage, when it is easily curable. To test according to the mentioned programmes, you have to address your family doctor, who will present you the programmes in detail and prescribe necessary analysis. After assessing the possibility of a disease, a patient will be provided with a plan of primary prevention tools; its implementation and efficiency will be monitored by the doctor. After assessing your health condition (if the analysis shows that you are referred to a high risk group), the doctor will send you for a more detailed analysis to specialized medical departments. You will be provided with long term prevention recommendations.

For people of a very high risk group, a plan of lifestyle, treatment and its monitoring will be formed.

We implement national health prevention programs funded from the compulsory health insurance budget.

Prevention program

Age group



Cervical cancer prevention program

Women 25-60   years old

To decrease the   women morbidity and mortality with cervical cancer, to detect early   pre-malignant disease of the cervix and stop the opportunity for cervical   cancer to develop

Once in 3 years,   a cervical screening is performed. After the results, biopsy may be done to   confirm or disprove the diagnosis objectively

Selective breast cancer screening program

Women 50-69   years old

To indicate   whether there are changes in a breast, to detect pre-malignant breast changes   or breast cancer as soon as possible. To decrease the women morbidity of   cancer

Once in 2 years,   mammography breast screening is performed. With a family doctor’s referral to   perform the mammography screening, you may register in advance (by coming or   by phone) at a medical institution that has mammography equipment. Family   doctors inform about the results when they receive them from institutions where   mammography is analyzed.

Funding program of bowel cancer early diagnostic

Persons 50-74   years old

To detect bowel   cancer in early stages while treatment is still effective. To diagnose the   disease is difficult as patients do not feel any symptoms of it for a long time, whereas to totally cure bowel cancer of a late stage (IV) is impossible

Once in 2 years,   occult bleeding test is performed. If the answer is negative- patients are   healthy, if positive- family doctors will refer patients to medical   specialists. Colonoscopy or biopsy are ways to confirm the bowel cancer   objectively

Funding program of prostate cancer early diagnostic

Men 50-69 years   old; men from 45 years old if their parents or brothers had prostate cancer

To detect   prostate cancer as soon as possible, because around 50 % of patients do not   feel any symptoms

Once in 2 years,   blood analysis is performed showing the concentration of prostate specific   antigen (PSA) in blood. If PSA exceeds the norm, family doctors refer   patients to consult urologists, they perform prostate cancer biopsy if in   need

Funding program of selection and prevention programs   for persons referred to a high risk cardiovascular disease groups

Men  40-55 and women 50-65 years old

To decrease   cardiovascular morbidity (angina pectoris, heart attack, cerebral   ischemia, stroke, peripheral arterial thrombosis). To select the sick with   diabetes or atherosclerosis that do not feel any health disorders, in order   to stop the development of these diseases

Once a year,   family doctors indicate risk factors and form individual cardiovascular   prevention plan, if necessary. If doctors indicate that the possibility of   cardiovascular diseases is big, they send patients to specialized centers for   detailed analysis, and the treatment is set, if necessary. It is important to   know that once a year glucoses, cholesterol, triglycerides concentration in   blood analysis, ECG and other analysis can be performed free-of-charge to   show whether patients belong to a high risk group